These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19324433)

  • 1. Homocysteine-lowering therapy for preventing atherothrombotic events: its role in high risk population.
    Acikel S; Dogan M; Akdemir R
    Int J Cardiol; 2010 Oct; 144(2):326-8. PubMed ID: 19324433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated.
    Kaul S; Zadeh AA; Shah PK
    J Am Coll Cardiol; 2006 Sep; 48(5):914-23. PubMed ID: 16949480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine and risk for atherothrombotic events.
    Puddu P
    Cardiologia; 1999 Jul; 44(7):627-31. PubMed ID: 10476587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperhomocysteinemia as a vascular risk factor in chronic hemodialysis patients].
    Trimarchi H; Young P; Díaz ML; Schropp J; Forrester M; Freixas E
    Medicina (B Aires); 2005; 65(6):513-7. PubMed ID: 16433478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia, atherosclerosis and thrombosis.
    Cattaneo M
    Thromb Haemost; 1999 Feb; 81(2):165-76. PubMed ID: 10063987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is plasma homocysteine a modifiable risk factor for stroke?
    Hankey GJ
    Nat Clin Pract Neurol; 2006 Jan; 2(1):26-33. PubMed ID: 16932518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocysteinemia: clinical and therapeutical involvement in venous thrombosis.
    Hoţoleanu C; Porojan-Iuga M; Rusu ML; Andercou A
    Rom J Intern Med; 2007; 45(2):159-64. PubMed ID: 18333369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased prevalence of hyperhomocysteinemia in cervical artery dissection causing stroke: a case-control study.
    Benninger DH; Herrmann FR; Georgiadis D; Kretschmer R; Sarikaya H; Schiller A; Baumgartner RW
    Cerebrovasc Dis; 2009; 27(3):241-6. PubMed ID: 19176957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinemia: an additional cardiovascular risk factor.
    Fanapour PC; Yug B; Kochar MS
    WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine and coronary heart disease.
    Clarke R; Lewington S
    Semin Vasc Med; 2002 Nov; 2(4):391-9. PubMed ID: 16222629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hyperhomocysteinemia on cardiovascular risk factors and initiation of atherosclerosis in Wistar rats.
    Sharma M; Rai SK; Tiwari M; Chandra R
    Eur J Pharmacol; 2007 Nov; 574(1):49-60. PubMed ID: 17706635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials.
    Antoniades C; Antonopoulos AS; Tousoulis D; Marinou K; Stefanadis C
    Eur Heart J; 2009 Jan; 30(1):6-15. PubMed ID: 19029125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms.
    Zhou J; Austin RC
    Biofactors; 2009; 35(2):120-9. PubMed ID: 19449439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Homocysteine, folic acid, group B vitamins and cardiovascular risk].
    Blacher J; Czernichow S; Horrellou MH; Conad J; David P; Chadefaux-Vekemans B; Ankria A; Galan P; Hercberg S; Ducimetière P
    Arch Mal Coeur Vaiss; 2005 Feb; 98(2):145-52. PubMed ID: 15787307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinemia and venous thrombosis.
    Bos GM; den Heijer M
    Semin Thromb Hemost; 1998; 24(4):387-91. PubMed ID: 9763356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinemia and atherothrombotic disease.
    de Jong SC; van den Berg M; Rauwerda JA; Stehouwer CD
    Semin Thromb Hemost; 1998; 24(4):381-5. PubMed ID: 9763355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of hyperhomocysteinaemia in atherothrombotic disease.
    Stehouwer DA
    Drugs Aging; 2000 Apr; 16(4):251-60. PubMed ID: 10874520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperhomocysteinemia. A new coronary risk factor].
    Zacarías-Castillo R; Hernández-Rebollar AE; Zajarias-Rabchinskey A; González-Bárcena D
    Gac Med Mex; 2001; 137(4):335-45. PubMed ID: 11519357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
    Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G
    G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.